January 2025 in “RSC Advances” The new delivery method for finasteride using nanoparticles may improve hair growth without skin issues.
December 2023 in “International Journal of Advanced Research in Science, Communication and Technology” A reliable method was created to measure Minoxidil and Finasteride in a solution.
July 2026 in “Postgraduate Medicine” Finasteride does not consistently cause depression.
July 2026 in “Postgraduate Medicine” Finasteride for hair loss often causes depression, with risks outweighing benefits.
Finasteride can cause depression and suicidal thoughts.
Finasteride can cause depression and suicidal thoughts.
July 2026 in “Journal of Dermatological Treatment” Finasteride and dutasteride both improve hair growth effectively, but dutasteride has stronger anti-androgen effects and finasteride may cause more sexual side effects.
July 2026 in “Journal of Drug Delivery and Therapeutics” The Finasteride-loaded gel may effectively treat hair loss with fewer side effects.
Finasteride and dutasteride are not recommended for feminizing therapy due to limited effectiveness and potential risks.
July 2026 in “Journal of the American Academy of Dermatology” Finasteride may lower depression risk in younger men with hair loss but increase it in older men with prostate issues.
June 2026 in “World Journal of Urology” Long-term finasteride use may lead to earlier use of ED medication and lower prostate cancer diagnosis rates.
June 2026 in “Zenodo (CERN European Organization for Nuclear Research)” Finasteride and dutasteride effectively treat hair loss, with dutasteride showing slightly better results.
June 2026 in “Zenodo (CERN European Organization for Nuclear Research)” Finasteride and dutasteride effectively treat hair loss, with dutasteride showing slightly better results.
June 2026 in “The Journal of Sexual Medicine” Finasteride 1 mg reduces semen quality without affecting hormones.
June 2026 in “The Pharmacogenomics Journal” June 2026 in “ChemistryOpen” Modified nanofibers improve finasteride skin absorption.
June 2026 in “EP Europace” Minoxidil and finasteride for hair loss may cause different types of heart rhythm issues.
May 2026 in “International Journal of Scientific Research in Chemistry” Finasteride breaks down into new compounds under acidic conditions.
May 2026 in “Reactions Weekly”
May 2026 in “Reactions Weekly” Finasteride and dutasteride may increase the risk of suicide and sexual dysfunction.
May 2026 in “RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218” Post-Finasteride Syndrome causes lasting sexual, mood, and metabolic issues, needing personalized treatment and better informed consent.
May 2026 in “Reactions Weekly” Finasteride may affect female fertility by altering gene activity.
Finasteride and dutasteride can harm male reproductive health, affecting sperm and causing sexual dysfunction.
May 2026 in “Journal on musculoskeletal ultrasound in pain medicine.” Chronic pelvic pain after finasteride may need pain education and rehab, not just medical treatments.
April 2026 in “Dermatology Practical & Conceptual” AMT may be more effective than finasteride for hair growth in androgenetic alopecia.
April 2026 in “The Journal of Urology” Finasteride and dutasteride reduce semen quality, with dutasteride having a stronger negative effect.
April 2026 in “The Journal of Urology” Finasteride 1 mg/day reduces semen quality without affecting hormones or sexual function.
April 2026 in “The Journal of Urology” Low-dose finasteride may increase erectile dysfunction risk over time.
April 2026 in “Open MIND” Microbes in the small intestine may cause Post-Finasteride Syndrome symptoms.